DaVita re-designs its leading online kidney disease resource

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), today announced the redesign and launch of DaVita.com, the leading online resource for information about kidney disease.

The new design makes it easier for patients and caregivers to find and use interactive tools, access a growing library of kidney disease education articles and explore more than 700 kidney-friendly recipes. Additionally, DaVita® launched new physician and hospital sites.

"For years, DaVita.com has been the premier online destination for dialysis patients and caregivers looking for a variety of tools and resources," said Kent Thiry, chairman and CEO of DaVita. "The new site enhances those features, improves navigation and expands content offerings for our physician partners and hospitals."

DaVita's award-winning website is one of the most popular online destinations for chronic kidney disease education and resources.

Highlights of the new DaVita.com include:

  • DaVita.com/physicians - features practice management tools, a new blog from Chief Medical Officer Allen Nissenson, top reads from Vice President of DaVita Clinical Research Mahesh Krishnan, thought leadership articles and more
  • DaVita.com/hospitals - offers information on strategic opportunities, services and potential cost savings
  • My DaVita - a social networking tool for patients that offers users the ability to tailor the DaVita.com experience and connect with others across the kidney care community
  • New design - reflects DaVita's commitment to improving quality of life for its patients, partners and teammates (employees), and improves navigation to critical information and state-of-the-art tools
Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NIH grants $2.6 million to explore the effects of high blood-pressure drugs in CKD patients